GenData Research Corp. agreed to provide genetic data to Celera Diagnostics for use in the latter's autoimmune disease research. (BioWorld Today)

Karo Bio AB is laying off 20 staff members as part of an overall effort to re-orient the company toward clinical development. (BioWorld International)

As its Phase III tesmilifene trial continues to enroll breast cancer patients, YM BioSciences Inc. entered a bought-deal agreement that could result in gross proceeds for the company of C$23 million (US$17.8 million). (BioWorld Today)